Status | Study |
Completed |
Study Name: Detection of Familial Hypercholesterolaemia in Cardiovascular Disease Registry Condition: Familial Hypercholesterolemia Cardiac Event Percutaneous C Date: 2016-05-12 |
Withdrawn |
Study Name: Evaluate the Efficacy and Safety of Lomitapide in Pediatric Patients With Homozygous Familial Hypercholesterolemia on Stable Lipid-lowering Therapy Condition: Homozygous Familial Hypercholesterolemia Date: 2016-04-27 Interventions: Drug: Lomitapide Other Name: Juxtapid, Lojuxta |
Active, not recruiting |
Study Name: A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-833) Condition: Hypercholesterolemia Familial Hypercholesterolemia Date: 2016-04-20 Interventions: Drug: Ezetimibe Drug: Rosuvastatin |
Completed |
Study Name: Postprandial Response After Intake of Meals With Different Fatty Acid Composition Condition: Healthy Familial Hypercholesterolemia Date: 2016-03-31 Interventions: Dietary Supplement: SFA muffin |
Recruiting |
Study Name: Efficacy and Safety of Gemcabene in Patients With Homozygous Familial Hypercholesterolemia on Stable, Lipid-Lowering Therapy (COBALT-1) Condition: Hypercholesteremia Date: 2016-03-12 Interventions: Drug: Gemcabene 300 mg 1-300 m |
Recruiting |
Study Name: The Spanish Familial Hypercholesterolaemia Cohort Study Condition: Familial Hypercholesterolaemia Date: 2016-02-09 |
Recruiting |
Study Name: A Gene Therapy Study for Homozygous Familial Hypercholesterolemia (HoFH) Condition: Homozygous Familial Hypercholesterolemia Date: 2016-01-04 Interventions: Biological: AAV directed hLDLR gene therapy A novel adeno-associated viral (AAV) vector with human low-d |
Recruiting |
Study Name: Open Label Study to Evaluate Safety, Tolerability and Efficacy of Evolocumab (AMG 145) in Pediatric Subjects (10 to 17 Years of Age) With Heterozygous Familial Hypercholesterolemia (HeFH) or Homozygous Familial Hypercholesterolemia (HoFH). Condition: Familial Hypercholesterolemia Date: 2015-10-22 Interventions: Biological: evolocumab (AMG 145) Administered by subcutaneous injection |
Completed |
Study Name: A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-384) Condition: Hypercholesterolemia Heterozygous Familial Hypercholesterolemia Date: 2015-05-29 Interventions: Drug: EZ 10 mg/Atorva 20 mg FDC |
Completed |
Study Name: Study to Evaluate the Effects of MBX-8025 in Patients With HoFH Condition: Homozygous Familial Hypercholesterolemia Date: 2015-05-22 Interventions: Other: Run-In Period: Placebo |